Clinical Trial

Comparative Efficacy of Antibiotics for Small Intestine Bacterial Overgrowth in Bangladeshi Children

Recruiting Phase 2
View on ClinicalTrials.gov →
Record status
This record was last updated May 6, 2026 (before its estimated August 2, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this Phase IIa study is to identify the most effective antibiotic regimen to treat small intestine bacterial overgrowth (SIBO) in impoverished Bangladeshi children.
Protocol Amendment History 3 changes
notable Primary completion pushed: 2026-06 -> 2026-08-02 2026-05-07
minor Completion pushed: 2026-06 -> 2026-09-01 2026-05-07
critical Recruitment opened 2026-04-24
Trial Details
NCT Number NCT07451171
Lead Sponsor University of Virginia
Collaborators: National Institutes of Health (NIH), International Centre for Diarrhoeal Disease Research, Bangladesh, Virginia Commonwealth University, Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Conditions Small Intestine Bacterial Overgrowth
Enrollment 60 participants
Start Date 2026-04-18
Primary Completion 2026-08-02 (estimated)
Study Completion 2026-09-01 (estimated)
Updated on ClinicalTrials.gov 2026-05-06